16th Conference on Retroviruses and Opportunistic Infections, Montreal, Canada, 8-11 February 2009.
Bhagani
Sanjay
S
Department of Infectious Diseases and HIV Medicine, Royal Free Hospital, London. sanjay.bhagani@royalfree.nhs.uk
D044966:Anti-Retroviral Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D018450:Disease Progression; D005838:Genotype; D015658:HIV Infections / Q000188:drug therapy / Q000453:epidemiology*; D006526:Hepatitis C / Q000188:drug therapy / Q000453:epidemiology* / Q000235:genetics; D006801:Humans; D008103:Liver Cirrhosis / Q000139:chemically induced / Q000517:prevention & control; D017093:Liver Failure / Q000453:epidemiology / Q000601:surgery / Q000821:virology; D016031:Liver Transplantation; D012367:RNA, Viral / Q000378:metabolism; D019562:Viral Load
D044966:Anti-Retroviral Agents; D000998:Antiviral Agents; D012367:RNA, Viral